UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 538

Sortiert nach

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Blood, 2017-10, Vol.130 (16), p.1857-1868

2017

Link zum Volltext

Verfügbarkeit prüfen

Decrease post-transplant relapse using donor-derived expanded NK-cells

Leukemia, 2022-01, Vol.36 (1), p.155-164

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (6), p.1316-1324

2021

Link zum Volltext

Verfügbarkeit prüfen

Maternal mortality and the lack of women-centered care in Brazil during COVID-19: Preliminary findings of a qualitative study

Lancet Regional Health - Americas (Online), 2022-06, Vol.10, p.100239-100239, Article 100239

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

Blood advances, 2020-11, Vol.4 (21), p.5580-5588

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Blood, 2020-10, Vol.136 (15), p.1786-1789

2020

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.51-56

2022

Link zum Volltext

Verfügbarkeit prüfen

Speaking truth to power: Legal scholars as survivors and witnesses of the Covid-19 maternal mortality in Brazil

International journal of constitutional law, 2022-07, Vol.20 (3), p.1360

2022

Link zum Volltext

Verfügbarkeit prüfen

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

British journal of haematology, 2016-05, Vol.173 (3), p.444-455

2016

Link zum Volltext

Verfügbarkeit prüfen

Tacrolimus‐associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation

American journal of hematology, 2013-04, Vol.88 (4), p.301-305

2013

Link zum Volltext

Verfügbarkeit prüfen

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Blood advances, 2021-12, Vol.5 (24), p.5599-5607

2021

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4207-4214

2013

Link zum Volltext

Verfügbarkeit prüfen

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2019-04, Vol.54 (4), p.601-606

2019

Link zum Volltext

Verfügbarkeit prüfen

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

Blood, 2009-04, Vol.113 (18), p.4144-4152

2009

Link zum Volltext

Verfügbarkeit prüfen

Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1746-1749

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells

The New England journal of medicine, 2002-03, Vol.346 (10), p.738-746

2002

Link zum Volltext

Verfügbarkeit prüfen

Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.745-748

2021

Link zum Volltext

Verfügbarkeit prüfen

Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy

Frontiers in immunology, 2022-10, Vol.13, p.1033871

2022

Link zum Volltext

Verfügbarkeit prüfen

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients

Annals of the American Thoracic Society, 2020-10, Vol.17 (10), p.1329-1333

2020

Link zum Volltext

Verfügbarkeit prüfen

Judicialization 2.0: Understanding right-to-health litigation in real time

Global public health, 2019-02, Vol.14 (2), p.190-199

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment of allosensitized patients receiving allogeneic transplantation

Blood advances, 2021-10, Vol.5 (20), p.4031-4043

2021

Link zum Volltext

Verfügbarkeit prüfen

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

Blood, 2011-03, Vol.117 (13), p.3641-3647

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 538

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(415)
Mit Volltextzugriff
(517)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(214)
Humans
(170)
Hematology
(154)
Middle Aged
(129)
Female
(126)
Adult
(124)
Male
(118)
Transplantation
(112)
Immunology
(102)
Aged
(85)
Hematology, Oncology And Palliative Medicine
(63)
Adolescent
(61)
Hematopoietic Stem Cell Transplantation
(60)
Young Adult
(58)
Treatment Outcome
(56)
Retrospective Studies
(54)
Oncology
(50)
Transplantation, Homologous
(46)
Stem Cell Transplantation
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Decrease post-transplant relapse using donor-derived expanded NK-cells

Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD

Maternal mortality and the lack of women-centered care in Brazil during COVID-19: Preliminary findings of a qualitative study

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

Speaking truth to power: Legal scholars as survivors and witnesses of the Covid-19 maternal mortality in Brazil

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

Tacrolimus‐associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation

Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells

Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients

Judicialization 2.0: Understanding right-to-health litigation in real time

Treatment of allosensitized patients receiving allogeneic transplantation

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

Suchergebnisse filtern